Secondary Logo

Institutional members access full text with Ovid®

Risks of Ovarian, Breast, and Corpus Uteri Cancer in Women Treated With Assisted Reproductive Technology in Great Britain, 1991–2010

Data Linkage Study Including 2.2 Million Person Years of Observation

Williams, Carrie L.; Jones, Michael E.; Swerdlow, Anthony J.; Botting, Beverley J.; Davies, Melanie C.; Jacobs, Ian; Bunch, Kathryn J.; Murphy, Michael F. G.; Sutcliffe, Alastair G.

Obstetrical & Gynecological Survey: February 2019 - Volume 74 - Issue 2 - p 89–90
doi: 10.1097/01.ogx.0000553097.89718.65
GYNECOLOGY: INFERTILITY/REPRODUCTIVE TECHNOLOGIES
Buy

(Abstracted from BMJ 2018;362:k2644)

Assisted reproductive therapy such as exposure of women to supraphysiological levels of estradiol, exogenous gonadotropins, and multiple ovarian punctures are suspected to incur an increased risk of cancer. Studies investigating the carcinogenic effects of these exposures are largely inconsistent.

UCL Great Ormond Street Institute of Child Health (C.L.W., B.J.B., A.G.S.); Institute of Cancer Research (M.E.J., A.J.S.); Institute for Women’s Health, University College London Hospitals (M.C.D., I.J.), London, United Kingdom; University of New South Wales, Sydney, Australia (I.J.); and National Perinatal Epidemiology Unit (K.J.B.), and Nuffield Department of Obstetrics and Gynaecology (M.F.G.M.), University of Oxford, Oxford, United Kingdom

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.